BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 22134565)

  • 1. Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus?
    Merola JF; Chang CA; Sanchez MR; Prystowsky SD
    J Drugs Dermatol; 2011 Dec; 10(12):1413-20. PubMed ID: 22134565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. Clinical and laboratory findings in seventeen patients.
    Callen JP
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):278-88. PubMed ID: 3871800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discoid lupus erythematosus as part of a larger disease spectrum. Correlation of clinical features with laboratory findings in lupus erythematosus.
    Prystowsky SD; Gilliam JN
    Arch Dermatol; 1975 Nov; 111(11):1448-52. PubMed ID: 1081865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti C1q antibodies in cutaneous lupus erythematosus.
    Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
    Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
    Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
    Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of discoid lupus erythematosus to mixed connective tissue disease.
    Gilliam JN; Prystowsky SD
    J Rheumatol; 1977; 4(2):165-9. PubMed ID: 881692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serologic and clinical features of patients with discoid lupus erythematosus: relationship of antibodies to single-stranded deoxyribonucleic acid and of other antinuclear antibody subsets to clinical manifestations.
    Callen JP; Fowler JF; Kulick KB
    J Am Acad Dermatol; 1985 Nov; 13(5 Pt 1):748-55. PubMed ID: 3878371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinuclear antibody studies in chronic cutaneous discoid lupus erythematosus.
    Prystowsky SD; Gilliam JN
    Arch Dermatol; 1977 Feb; 113(2):183-6. PubMed ID: 300002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus with generalized chronic cutaneous (discoid) lupus erythematosus.
    Dadlani C; Pulitzer M; Prystowsky SD
    Dermatol Online J; 2008 May; 14(5):5. PubMed ID: 18627741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA; Mbuagbaw J; Burge SM
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal outcome and predictors of clinical renal involvement in patients with silent lupus nephritis.
    Wada Y; Ito S; Ueno M; Nakano M; Arakawa M; Gejyo F
    Nephron Clin Pract; 2004; 98(4):c105-11. PubMed ID: 15627787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD; Patwardhan MM; Ghosh K
    Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Soluble interleukin 2 receptor as activity parameter in serum of systemic and discoid lupus erythematosus].
    Blum C; Zillikens D; Tony HP; Hartmann AA; Burg G
    Hautarzt; 1993 May; 44(5):290-5. PubMed ID: 8320115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic lupus erythematosus presenting as acneiform lesions].
    Deruelle-Khazaal R; Ségard M; Cottencin-Charrière AC; Carotte-Lefebvre I; Thomas P
    Ann Dermatol Venereol; 2002; 129(6-7):883-5. PubMed ID: 12218916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.
    Suleiman S; Kamaliah D; Nadeem A; Naing NN; Che Maraina CH
    Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silent renal disease in systemic lupus erythematosus.
    Font J; Torras A; Cervera R; Darnell A; Revert L; Ingelmo M
    Clin Nephrol; 1987 Jun; 27(6):283-8. PubMed ID: 3497000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.